Pancrelipase
From Self-sufficiency
| Identifiers | |
|---|---|
| CAS Number | 53608-75-6 |
| ATC code | none |
| DrugBank | DB00085 |
| Chemical data | |
| Formula | C5850H8902N1606O1739S49 |
| Molar mass | 131 kDa[[Script error: No such module "String".]] |
Pancrelipase is a form of enzyme therapy for the treatment of various digestive disorders, primarily exocrine pancreatic insufficiency. It is a mixture of three digestive enzymes, amylase, trypsin, and lipase, which are normally produced by the pancreas. Pancrelipase is used by people with cystic fibrosis whose pancreatic ducts are blocked with mucus. The blockage prevents digestive enzymes that are made by the pancreas from reaching the intestines, where they are needed for digestion. This is also used with people with chronic pancreatitis.
Brand names for Pancrelipase include Ultrase.
External links
 |
This pharmacology-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Infobox drug articles without a structure image
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Pharmacology stubs
- Enzymes
- 2Fix
